2seventy bio (TSVT) has released an update to notify the public and investors about a regulation fd disclosure.
On January 30, 2024, the Company announced an Asset Sale and accompanying changes in its leadership through a press release. This press release, along with the information in the Current Report, is not considered filed under the Securities Exchange Act of 1934 and is not subject to its liabilities, nor is it to be included in any filings under the Securities Act of 1933, unless specifically referenced.
For further insights into TSVT stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
